CIC BiomaGUNE
Centro (uo)
Instituto de Investigación Sanitaria Gregorio Marañón
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Gregorio Marañón (6)
2023
-
Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model (Frontiers in Pharmacology, (2023), 14, (1021535), 10.3389/fphar.2023.1021535)
Frontiers in Pharmacology
-
Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model
Frontiers in Pharmacology, Vol. 14
2021
-
Human influenza A virus causes myocardial and cardiac-specific conduction system infections associated with early inflammation and premature death
Cardiovascular research, Vol. 117, Núm. 3, pp. 876-889
2020
-
Probiotic Bifidobacterium breve prevents DOCA-salt hypertension
FASEB Journal, Vol. 34, Núm. 10, pp. 13626-13640
2019
2016
-
Effects of quercetin in a rat model of hemorrhagic traumatic shock and reperfusion
Molecules, Vol. 21, Núm. 12